Adding to its investment in positron imaging, Integral Nuclear Associates has purchased the assets of Nuclear Imaging Systems and Cardiovascular Concepts. These assets include 14 fixed-site nuclear cardiology imaging centers in Pennsylvania, New Jersey,
Adding to its investment in positron imaging, Integral Nuclear Associates has purchased the assets of Nuclear Imaging Systems and Cardiovascular Concepts. These assets include 14 fixed-site nuclear cardiology imaging centers in Pennsylvania, New Jersey, Delaware, and Maryland. The sellers had filed for bankruptcy under chapter 11 in August 2000. INA, which owns Integral PET, intends to incorporate its newly acquired sites into the nuclear cardiology business operated by the Integral group of companies. The centers provide a comprehensive range of nuclear cardiology services, including cardiac stress tests, SPECT, perfusion, and wall motion studies.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.